{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:46Z","timestamp":1791267886074,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1245\/s10434-015-4865-9","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T14:21:03Z","timestamp":1446733263000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure"],"prefix":"10.1245","volume":"23","author":[{"given":"Naris","family":"Nilubol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"4865_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/edrv-8-4-391","volume":"8","author":"ML Brandi","year":"1987","unstructured":"Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev. 1987;8:391\u2013405.","journal-title":"Endocr Rev."},{"key":"4865_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.beem.2010.01.003","volume":"24","author":"JM Sharretts","year":"2010","unstructured":"Sharretts JM, Simonds WF. Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab. 2010;24:491\u2013502.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"4865_CR3","first-page":"5553","volume":"60","author":"S Uchino","year":"2000","unstructured":"Uchino S, Noguchi S, Sato M, et al. Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res. 2000;60:5553\u20137.","journal-title":"Cancer Res."},{"key":"4865_CR4","first-page":"555","volume":"10","author":"HF Vasen","year":"1990","unstructured":"Vasen HF, Griffioen G, Lips CJ, Struyvenberg A, van Slooten EA. Screening of families predisposed to cancer development in The Netherlands. Anticancer Res. 1990;10:555\u201363.","journal-title":"Anticancer Res."},{"key":"4865_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","volume":"70","author":"CR Pieterman","year":"2009","unstructured":"Pieterman CR, Schreinemakers JM, Koppeschaar HP, et al. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clin Endocr. 2009;70:575\u201381.","journal-title":"Clin Endocr."},{"key":"4865_CR6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","volume":"124","author":"SE Carty","year":"1998","unstructured":"Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery. 1998;124:1106\u201313; discussion 1113\u20131104.","journal-title":"Surgery."},{"key":"4865_CR7","first-page":"943","volume-title":"The metabolic and molecular bases of inherited disease","author":"SJ Marx","year":"2001","unstructured":"Marx SJ. Multiple endocrine neoplasia type 1. In: Scriver CB, Beaudet AL; Sly WS, et al (ed) The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. P. 943\u201366.","edition":"8"},{"key":"4865_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1245\/ASO.2006.12.009","volume":"13","author":"CH Lee","year":"2006","unstructured":"Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol. 2006;13:103\u20139.","journal-title":"Ann Surg Oncol."},{"key":"4865_CR9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","volume":"255","author":"CR Pieterman","year":"2012","unstructured":"Pieterman CR, van Hulsteijn LT, den Heijer M, et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012;255:1171\u20138.","journal-title":"Ann Surg."},{"key":"4865_CR10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","volume":"134","author":"DM Elaraj","year":"2003","unstructured":"Elaraj DM, Skarulis MC, Libutti SK, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858\u201364; discussion 864\u2013855","journal-title":"Surgery."},{"key":"4865_CR11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","volume":"35","author":"JM Schreinemakers","year":"2011","unstructured":"Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Rinkes IH. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg. 2011;35:1993\u20132005.","journal-title":"World J Surg."},{"key":"4865_CR12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-2001-16944","volume":"33","author":"M Katai","year":"2001","unstructured":"Katai M, Sakurai A, Ikeo Y, Hashizume K. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res. 2001;33:499\u2013503.","journal-title":"Horm Metab Res."},{"key":"4865_CR13","first-page":"1080","volume":"112","author":"JL Kraimps","year":"1992","unstructured":"Kraimps JL, Duh QY, Demeure M, Clark OH. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992;112:1080\u20136; discussion 1086\u20138.","journal-title":"Surgery."},{"key":"4865_CR14","first-page":"958","volume":"102","author":"JA Norton","year":"1987","unstructured":"Norton JA, Cornelius MJ, Doppman JL, Maton PN, Gardner JD, Jensen RT. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery. 1987;102:958\u201366.","journal-title":"Surgery."},{"key":"4865_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000658-198101000-00004","volume":"193","author":"RA Prinz","year":"1981","unstructured":"Prinz RA, Gamvros OI, Sellu D, Lynn JA. Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg. 1981;193:26\u20139.","journal-title":"Ann Surg."},{"key":"4865_CR16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s002689900430","volume":"22","author":"C Proye","year":"1998","unstructured":"Proye C, Carnaille B, Quievreux JL, Combemale F, Oudar C, Lecomte-Houcke M. Late outcome of 304 consecutive patients with multiple gland enlargement in primary hyperparathyroidism treated by conservative surgery. World J Surg. 1998;22:526\u20139; discussion 529\u201330.","journal-title":"World J Surg."},{"key":"4865_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00423-008-0408-1","volume":"393","author":"A Slepavicius","year":"2008","unstructured":"Slepavicius A, Beisa V, Janusonis V, Strupas K. Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial. Langenbecks Arch Surg. 2008;393:659\u201366.","journal-title":"Langenbecks Arch Surg."},{"key":"4865_CR18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF02067367","volume":"16","author":"P Hellman","year":"1992","unstructured":"Hellman P, Skogseid B, Juhlin C, Akerstrom G, Rastad J. Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg. 1992;16:718\u201322; discussion 722\u2013713.","journal-title":"World J Surg."},{"key":"4865_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.surg.2013.03.004","volume":"154","author":"M Versnick","year":"2013","unstructured":"Versnick M, Popadich A, Sidhu S, Sywak M, Robinson B, Delbridge L. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1 primary hyperparathyroidism. Surgery. 2013;154:101\u20135.","journal-title":"Surgery."},{"key":"4865_CR20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1245\/s10434-011-2092-6","volume":"19","author":"RS Prichard","year":"2011","unstructured":"Prichard RS, O\u2019Neill CJ, Oucharek JJ, et al. Is focused minimally invasive parathyroidectomy appropriate for patients with familial primary hyperparathyroidism? Ann Surg Oncol. 2011;19:1264\u20138.","journal-title":"Ann Surg Oncol."},{"key":"4865_CR21","first-page":"397","volume":"54","author":"SJ Marx","year":"1999","unstructured":"Marx SJ, Agarwal SK, Kester MB, et al. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res. 1999;54:397\u2013438; discussion 438\u201399.","journal-title":"Recent Prog Horm Res."},{"key":"4865_CR22","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658\u201371.","journal-title":"J Clin Endocrinol Metab."},{"key":"4865_CR23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00268-012-1451-1","volume":"36","author":"N Nilubol","year":"2012","unstructured":"Nilubol N, Weinstein L, Simonds WF, et al. Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit? World J Surg. 2012;36:1368\u201374.","journal-title":"World J Surg."},{"key":"4865_CR24","first-page":"2186","volume":"36","author":"CC Chen","year":"1995","unstructured":"Chen CC, Skarulis MC, Fraker DL, Alexander R, Marx SJ, Spiegel AM. Technetium-99\u00a0m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med. 1995;36:2186\u201391.","journal-title":"J Nucl Med."},{"key":"4865_CR25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1067\/msy.2000.109963","volume":"128","author":"DL Feingold","year":"2000","unstructured":"Feingold DL, Alexander HR, Chen CC, et al. Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery. 2000;128:1103\u20139; discussion 1109\u201310.","journal-title":"Surgery."},{"key":"4865_CR26","first-page":"1031","volume":"114","author":"DS O\u2019Riordain","year":"1993","unstructured":"O\u2019Riordain DS, O\u2019Brien T, Grant CS, Weaver A, Gharib H, van Heerden JA. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 1993;114:1031\u20137; discussion 1037\u20139.","journal-title":"Surgery."},{"key":"4865_CR27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","volume":"134","author":"JR Burgess","year":"1999","unstructured":"Burgess JR, David R, Greenaway TM, Parameswaran V, Shepherd JJ. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg. 1999;134:1119\u201323.","journal-title":"Arch Surg."},{"key":"4865_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/110241501750099294","volume":"167","author":"C Dotzenrath","year":"2001","unstructured":"Dotzenrath C, Cupisti K, Goretzki PE, et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg. 2001;167:173\u20138.","journal-title":"Eur J Surg."},{"key":"4865_CR29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167\u2013214.","journal-title":"Thyroid."},{"key":"4865_CR30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","volume":"25","author":"P Goudet","year":"2001","unstructured":"Goudet P, Cougard P, Verges B, et al. Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D\u2019etude des Neoplasies Endocriniennes Multiples Study Group. World J Surg. 2001;25:886\u201390.","journal-title":"World J Surg."},{"key":"4865_CR31","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s00268-013-2054-1","volume":"37","author":"N Nilubol","year":"2013","unstructured":"Nilubol N, Weisbrod AB, Weinstein LS, et al. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy. World J Surg. 2013;37:1966\u201372.","journal-title":"World J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4865-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4865-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4865-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:22:10Z","timestamp":1559632930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4865-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["4865"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4865-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}